You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team
Regimen
Published Date: 26 Mar 2026
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/uses section (Added HR+, HER2-low or HER2-ultralow breast cancer – universal compassionate supply may be available)

Updated
Mar 2026
Drug

Published Date: 26 Mar 2026

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Mar 2026
Regimen
Published Date: 25 Mar 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Formatting change only

Updated
Mar 2026
Drug

Published Date: 25 Mar 2026

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d'information mise à jour/revisée)
Updated
Mar 2026
Regimen
Published Date: 24 Mar 2026
Cancer Type:
Gastrointestinal, 
Mesothelioma (Peritoneal), 
Lung, 
Mesothelioma (Pleural)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: New patient regimen information sheet
Updated
Mar 2026
Regimen
Published Date: 24 Mar 2026
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Revision Summary:
Patient Info Sheet EN: New patient regimen information sheet
Updated
Mar 2026
Drug

Published Date: 18 Mar 2026

Revision Summary:


Drug Monograph: Updated Supplementary Public Funding section

Updated
Mar 2026
Regimen
Published Date: 18 Mar 2026
Cancer Type:
Gynecologic, 
Endometrial
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses and Cycle Frequency sections

Updated
Mar 2026
Regimen
Published Date: 26 May 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

May 2025
Regimen
Published Date: 17 Mar 2026
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant, Palliative
Revision Summary:

Regimen Monograph: Modified Special Precautions, Pregnancy/Lactation, and Monitoring sections

Updated
Mar 2026
Regimen
Published Date: 17 Mar 2026
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant, Palliative
Revision Summary:

Regimen Monograph: Modified Special Precautions and Pregnancy/Lactation sections

Updated
Mar 2026
Drug

Published Date: 17 Mar 2026

Revision Summary:
Drug Monograph: Removed Lupron® (short acting) - product discontinued
Updated
Mar 2026

Pages